02 August 2012 08:32

EC raises concern at Visa Europe on credit card interchange fees

Visa Europe

European regulators have formally raised concerns that consumers could be paying too much because of fees charged by Visa to process cross-border credit card transactions.

The European Commission told Visa of its concerns about "possible violations of EU antitrust rules" relating to Visa's "multilateral interchange fees" (MIFs) system, which charges retailers for the transactions they handle. 

In a supplementary statement, the Commission says that its preliminary view is that the Visa multilateral interchange fees (MIFs) for consumer credit cards violate its rules designed to stop cartels and restrictive business practices.

The EC says it thinks that MIFs "harm competition between acquiring banks, inflate the cost of payment card acceptance for merchants and ultimately increase consumer prices".

It also "doubts" that Visa's MIFs are "necessary to create efficiencies that benefit merchants and consumers" and could therefore be entitled to an exception from the rules. 

The supplementary statement is the latest stage in a lengthy battle that saw Visa slash its multilateral interchange fees for debit cards in late 2010 but refuse to back down credit cards.

Visa can now make a written reply or ask for a hearing on the issue which could see fines imposed of up to 10% of turnover imposed for antitrust breaches,

Responding to the new development, Peter Ayliffe, CEO, Visa Europe, says: "We are very disappointed that the Commission has taken such a confrontational approach and was not willing to find a solution to support investment and innovation in European payments for the benefit of European consumers and to allow European payments to compete globally." 

In May an EU court dismissed Visa rival MasterCard's challenge against an EC ruling that the firm's cross-border interchange fees for both credit and debit cards violated competition law.

Meanwhile, both card giants are facing interchange problems in the US: having agreed a $7.25 billion class action settlement with retailers earlier this month, several major merchants, including Walmart, have now come out against the plan.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
03 Mar
OMXC20
Kære alle brugere af EI,   Da EI tilsyneladende ikke bekymrer sig besynderligt omkring debat niveaue..
34
01 Mar
VWS
God søndag til alle.   Jeg faldt over denne timelapse-video der viser flere detaljer end normalt omk..
25
04 Mar
BAVA
HISTORISK dag med den ved "best case scenario" meget lukrative partneraftale med BMS vedrørende Pros..
17
01 Mar
 
For første gang i mange år har jeg prøvet at krydstabulere på EET depot, - inden revisoren får det. ..
15
27 Feb
OMXC20
Med al respekt...   Det kan ikke afvises der kommer en mindre korrektion fra tid til anden, men spør..
13
01 Mar
 
Hej, Så er vi igennem uge 8 & 9 og finanshusene har opdateret deres estimater for 2015 de nordiske ..
12
28 Feb
SAS-DKK
Man burde betale folk en ordentlig og en anstændig løn for deres arbejde.   På sigt vil ingen jo arb..
12
27 Feb
OMXC20
Om få dage starter ECB's obligationsopkøb på 60mia+ euro om måneden i mindst 18 måneder. Det vil sæn..
11
04 Mar
I:SP500
Mobe: Er du her stadig? Så dit indlæg den anden dag og her er et forsøg på et seriøst indlæg. Enjoy ..
10
02 Mar
SAS
Selvfølgelig bliver det ikke den sidste. Når fronterne er trukket så hårdt op betyder det at der opb..
10

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Gemalto full year 2014 results
2
Atos announces new line of Big-Data appliances for SAP HANA® based on bullion S
3
WellCare to Present at the Barclays Global Healthcare Conference
4
Presentation held at the North Atlantic Seafood Conference 4 March
5
Laredo Petroleum Prices Offering of $350 Million of Senior Notes

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
05 March 2015 08:01:27
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150225.2 - EUROWEB7 - 2015-03-05 09:01:27 - 2015-03-05 08:01:27 - 1000 - Website: OKAY